Holen Sie sich die Stockscreener-App
1.32
0.00%
0.00
Bionexus Gene Lab Corp Aktie (BGLC) Neueste Nachrichten
BioNexus Says VitaGuard Blood Tests Could Cost Under $300 - Stock Titan
BGLC|BioNexus Gene Lab Corp|Price:1.370|Chg%:-0.140 - TradingKey
BGLC|BioNexus Gene Lab Corp|Price:1.450|Chg%:-0.060 - TradingKey
BioNexus Gene Lab Corp Revenue Breakdown – NASDAQ:BGLC - TradingView
BioNexus Gene Lab Corp (BGLC) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
BioNexus Gene Lab Corp (BGLC) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
BGLC|BioNexus Gene Lab Corp|Price:1.510|Chg%:-0.050 - TradingKey
BioNexus Gene Lab Corp (BGLC) Cash Flow - TradingKey
TradingKey - TradingKey
BioNexus Gene Lab Corp (BGLC) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
BioNexus Gene Lab Corp (BGLC) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
BioNexus Gene Lab Corp (BGLC) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
12 Industrials Stocks Moving In Thursday's Pre-Market SessionEos Energy Enterprises, Inc.Right (NAS - Benzinga
Price to sales forward of BioNexus Gene Lab Corp – NASDAQ:BGLC - TradingView
Enterprise value to revenue forward of BioNexus Gene Lab Corp – NASDAQ:BGLC - TradingView
Number of shareholders of BioNexus Gene Lab Corp – NASDAQ:BGLC - TradingView
BioNexus Gene Lab Corp (BGLC) Edges Higher as Shares Test Key ResistanceMoney Flow Index - dars.gov.et
Enterprise value to EBITDA forward of BioNexus Gene Lab Corp – NASDAQ:BGLC - TradingView
BioNexus Gene Lab Company Profile & Introduction - Moomoo
Price to earnings forward of BioNexus Gene Lab Corp – NASDAQ:BGLC - TradingView
Price to book forward of BioNexus Gene Lab Corp – NASDAQ:BGLC - TradingView
AI Investing InsightsOfficial HomepageIntellectia AI™ - Intellectia AI
BioNexus Gene Lab Corp (BGLC) Slips 6.95% as Shares Test Key Support LevelsGEX Level - Město Břeclav
BioNexus Gene Lab Corp (BGLC) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
BioNexus Gene Lab Corp (BGLC) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
BioNexus Gene Lab Corp (BGLC) Institutional Confidence - TradingKey
BioNexus Gene Lab Corp (BGLC) Valuation: PE, PB & Fair Value Analysis - TradingKey
BioNexus Gene Lab Corp (BGLC) Edges Higher as Shares Hold Above Key Support at $2.47Channel Breakout - newsline.com
BioNexus Gene Lab Corp (BGLC) Slips 4.1%: Testing Key Support at $2.09Elliott Wave Entry - newsline.com
BioNexus Gene Lab Calls for Malaysia–China Biotech Co-Development and Precision Healthcare Collaboration 1 - Minichart
BioNexus Gene Lab Urges Malaysia–China Co-Development of Biotech Platforms After Kuala Lumpur Forum - TradingView
BioNexus Gene Lab (Nasdaq: BGLC) pushes Malaysia–China biotech co-development model - Stock Titan
BioNexus Gene Lab Corp (BGLC) Slips 2.37% as Stock Tests Key Support AreaAscending Triangle - DonanımHaber
BioNexus Gene Lab Corp (BGLC) Declines 8.33% as Stock Approaches Key SupportHigh Beta Stocks - The Legal Advocate
BioNexus Gene Lab Corp (BGLC) Slides 4.17% as Support Level Nears – Key Levels to WatchRating Change - newsline.com
BioNexus Gene Lab Corp (BGLC) Slides 6.25%: Key Support Zone Under ScrutinyCash Flow Strong Stocks - The Legal Advocate
BioNexus Gene Lab Corp. Calls for Malaysia-China Biotechnology Collaboration Focused on Joint Development - geneonline.com
BioNexus Gene Lab Corp. Calls for Malaysia–China - GlobeNewswire
Turning Malaysia into a bridge for China’s biotech ambitions - Stock Titan
BGLCBioNexus Gene Lab Corp Stock Price and Quote - Finviz
BioNexus Gene Lab Stock Edges Up While Nasdaq Microcap Faces Chemrex Cash Battle - Bez Kabli
12 Industrials Stocks Moving In Wednesday's After-Market Session - Sahm
BioNexus Gene Lab Corp (BGLC) Surges 8.44%: Testing Key Resistance at $2.30Channel Breakout - The Legal Advocate
BioNexus Gene Lab (BGLC) Extends Decline, Tests Key Support at $1.92Crowd Entry Signals - Newser
BioNexus Gene Lab Corp 1Q 2026: Revenue $22.84K, EPS ($0.23) — 10-Q Summary - TradingView
BioNexus Gene Lab Corp. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
[10-Q] BioNexus Gene Lab Corp Quarterly Earnings Report - Stock Titan
BGLC | BioNexus Gene Lab Corp Insider Trading - Quiver Quantitative
Is BioNexus Lab (BGLC) stock fading in strength |Community Buy Alerts - newser.com
BioNexus Lab (BGLC) Risk Reward Ratio | BioNexus Gene Lab posts strong revenue, net lossCertified Trade Ideas - Xã Vĩnh Công
0.00%
0.90%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):